Taiwan
· Delayed Price · Currency is TWD Grape King Bio Statistics
Total Valuation
Grape King Bio has a market cap or net worth of TWD 19.33 billion. The enterprise value is 17.49 billion.
| Market Cap | 19.33B |
| Enterprise Value | 17.49B |
Important Dates
The next estimated earnings date is Thursday, August 14, 2025.
| Earnings Date | Aug 14, 2025 |
| Ex-Dividend Date | Jun 23, 2025 |
Share Statistics
Grape King Bio has 148.14 million shares outstanding. The number of shares has increased by 0.01% in one year.
| Current Share Class | 148.14M |
| Shares Outstanding | 148.14M |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | -0.62% |
| Owned by Insiders (%) | 12.23% |
| Owned by Institutions (%) | 21.51% |
| Float | 115.07M |
Valuation Ratios
The trailing PE ratio is 13.91.
| PE Ratio | 13.91 |
| Forward PE | n/a |
| PS Ratio | 1.75 |
| PB Ratio | 1.68 |
| P/TBV Ratio | 2.02 |
| P/FCF Ratio | 16.04 |
| P/OCF Ratio | 10.88 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.90, with an EV/FCF ratio of 14.51.
| EV / Earnings | 12.51 |
| EV / Sales | 1.58 |
| EV / EBITDA | 5.90 |
| EV / EBIT | 7.10 |
| EV / FCF | 14.51 |
Financial Position
The company has a current ratio of 1.64, with a Debt / Equity ratio of 0.02.
| Current Ratio | 1.64 |
| Quick Ratio | 1.37 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.08 |
| Debt / FCF | 0.20 |
| Interest Coverage | 736.15 |
Financial Efficiency
Return on equity (ROE) is 17.91% and return on invested capital (ROIC) is 12.71%.
| Return on Equity (ROE) | 17.91% |
| Return on Assets (ROA) | 9.99% |
| Return on Invested Capital (ROIC) | 12.71% |
| Return on Capital Employed (ROCE) | 20.66% |
| Revenue Per Employee | 22.09M |
| Profits Per Employee | 2.79M |
| Employee Count | 501 |
| Asset Turnover | 0.72 |
| Inventory Turnover | 3.16 |
Taxes
In the past 12 months, Grape King Bio has paid 490.94 million in taxes.
| Income Tax | 490.94M |
| Effective Tax Rate | 18.87% |
Stock Price Statistics
The stock price has decreased by -17.53% in the last 52 weeks. The beta is 0.49, so Grape King Bio's price volatility has been lower than the market average.
| Beta (5Y) | 0.49 |
| 52-Week Price Change | -17.53% |
| 50-Day Moving Average | 133.20 |
| 200-Day Moving Average | 144.25 |
| Relative Strength Index (RSI) | 36.81 |
| Average Volume (20 Days) | 162,135 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Grape King Bio had revenue of TWD 11.06 billion and earned 1.40 billion in profits. Earnings per share was 9.38.
| Revenue | 11.06B |
| Gross Profit | 8.55B |
| Operating Income | 2.44B |
| Pretax Income | 2.60B |
| Net Income | 1.40B |
| EBITDA | 2.88B |
| EBIT | 2.44B |
| Earnings Per Share (EPS) | 9.38 |
Balance Sheet
The company has 3.95 billion in cash and 244.83 million in debt, giving a net cash position of 3.71 billion or 25.02 per share.
| Cash & Cash Equivalents | 3.95B |
| Total Debt | 244.83M |
| Net Cash | 3.71B |
| Net Cash Per Share | 25.02 |
| Equity (Book Value) | 11.53B |
| Book Value Per Share | 65.26 |
| Working Capital | 2.01B |
Cash Flow
In the last 12 months, operating cash flow was 1.78 billion and capital expenditures -570.93 million, giving a free cash flow of 1.21 billion.
| Operating Cash Flow | 1.78B |
| Capital Expenditures | -570.93M |
| Free Cash Flow | 1.21B |
| FCF Per Share | 8.14 |
Margins
Gross margin is 77.28%, with operating and profit margins of 22.05% and 12.64%.
| Gross Margin | 77.28% |
| Operating Margin | 22.05% |
| Pretax Margin | 23.51% |
| Profit Margin | 12.64% |
| EBITDA Margin | 26.07% |
| EBIT Margin | 22.05% |
| FCF Margin | 10.89% |
Dividends & Yields
This stock pays an annual dividend of 6.90, which amounts to a dividend yield of 5.29%.
| Dividend Per Share | 6.90 |
| Dividend Yield | 5.29% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 101.72% |
| Buyback Yield | -0.01% |
| Shareholder Yield | 5.42% |
| Earnings Yield | 7.23% |
| FCF Yield | 6.23% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 15, 2005. It was a forward split with a ratio of 1.0205.
| Last Split Date | Sep 15, 2005 |
| Split Type | Forward |
| Split Ratio | 1.0205 |
Scores
Grape King Bio has an Altman Z-Score of 5.86 and a Piotroski F-Score of 5.
| Altman Z-Score | 5.86 |
| Piotroski F-Score | 5 |